The Etiometry Platform elevates clinical staff performance and identifies areas requiring urgent attention for better clinical outcomes, shorter hospital stays, and enhanced revenue opportunities. SAN ANTONIO, TX. – November 29th, 2022 – Frost & Sullivan recently assessed the US clinical decision support for the critical care industry and, based on its findings, recognizes Etiometry with the 2022 US Clinical […]

This marks the latest regulatory approval for Etiometry as the second adult and third pediatric market authorization October 12, 2022 08:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for critical care, announced today that the company has obtained the CE Mark under the European Union’s medical device regulation, marking the […]

BOSTON, Mass. – July 12, 2022 – Etiometry, a leader in clinical decision-support software for critical care, announced today that it has doubled its FDA-cleared risk analytics portfolio to four indices, further strengthening its capability to track the fundamental pathways through which patients deteriorate under intensive care. Etiometry is the only critical care AI decision-support company […]

Leading Intensive Care Clinical Decision-Support Software and Acute Care Diagnostics Medical Device Provider Announce Partnership BOSTON, Mass. & BREA, Cal. – June 30, 2022 – Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, today announced a new collaboration to enhance the clinical […]

Healthcare providers across Canada can now implement the IDO2 Index for adult patients in the ICU, which provides a risk estimation of inadequate oxygen delivery June 06, 2022 08:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for critical care, today announced the first market authorization of the company’s IDO2 Index […]